Who owns Mereo Biopharma Group Plc ads?
- Ticker: MREO
- CUSIP Number: 589492107
Tip: Access positions for across all investors
Analyze quarterly positions in Mereo Biopharma Group Plc ads with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Mereo Biopharma Group Plc ads stock
Who bought or sold Mereo Biopharma Group Plc ads this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Rubric Capital Management | 15M | $63M | 0% | Sep 2024 |
|
| Rock Springs Capital Management | 9.3M | $33M | 14% | Jun 2024 |
|
| Henderson Group | 7.9M | $28M | 54% | Jun 2024 |
|
| Deerfield Management Company | 6.7M | $28M | 0% | Sep 2024 |
|
| Frazier Life Sciences Management | 5.1M | $21M | 16% | Sep 2024 |
|
| 683 Capital Management | 4.8M | $20M | -3% | Sep 2024 |
|
| Clearline Capital | 3.2M | $13M | -2% | Sep 2024 |
|
| Tejara Capital | 2.8M | $12M | 15% | Sep 2024 |
|
| Goldman Sachs Group | 2.5M | $9.0M | 12% | Jun 2024 |
|
| Renaissance Technologies | 1.3M | $5.4M | -26% | Sep 2024 |
|
| Soleus Capital Management | 1.2M | $4.5M | -52% | Jun 2024 |
|
| Marshall Wace | 1.0M | $4.2M | -10% | Sep 2024 |
|
| Blue Owl Capital Holdings | 848k | $3.5M | -6% | Sep 2024 |
|
| NEOS Investment Management | 835k | $3.4M | 34% | Sep 2024 |
|
| Perceptive Advisors | 816k | $3.4M | -35% | Sep 2024 |
|
| Susquehanna International | 736k | $3.0M | -29% | Sep 2024 |
|
| Jane Street | 423k | $1.7M | 400% | Sep 2024 |
|
| Artia Global Partners | 421k | $1.7M | 0% | Sep 2024 |
|
| Monaco Asset Management SAM | 385k | $1.6M | 10% | Sep 2024 |
|
| Knott David M Jr | 331k | $1.4M | 40% | Sep 2024 |
|
| Citadel Advisors | 261k | $1.1M | -51% | Sep 2024 |
|
| Knoll Capital Management | 261k | $1.1M | 0% | Sep 2024 |
|
| J. Goldman & Co | 228k | $820k | -18% | Jun 2024 |
|
| Verition Fund Management | 227k | $815k | -53% | Jun 2024 |
|
| Bank of America Corporation | 218k | $894k | 159% | Sep 2024 |
|
| Morgan Stanley | 208k | $831k | -85% | Jun 2024 |
|
| Two Sigma Investments | 202k | $726k | -43% | Jun 2024 |
|
| HealthInvest Partners AB | 200k | $822k | 100% | Sep 2024 |
|
| Polar Securities | 198k | $815k | 36% | Sep 2024 |
|
| Hudson Bay Capital Management | 175k | $719k | 100% | Sep 2024 |
|
| Fred Alger Management | 103k | $422k | 108% | Sep 2024 |
|
| Geode Capital Management | 92k | $379k | 0% | Sep 2024 |
|
| Suvretta Capital Management | 75k | $270k | -98% | Jun 2024 |
|
| GSA Capital Partners | 67k | $276k | 100% | Sep 2024 |
|
| PRIMECAP Management Company | 54k | $222k | 0% | Sep 2024 |
|
| Clear Harbor Asset Management | 44k | $179k | 0% | Sep 2024 |
|
| Simplex Trading | 34k | $139k | -18% | Sep 2024 |
|
| Forefront Analytics | 34k | $139k | -7% | Sep 2024 |
|
| Qube Research & Technologies | 33k | $120k | -70% | Jun 2024 |
|
| Hsbc Holdings | 29k | $100k | 0% | Jun 2024 |
|
| Squarepoint Ops | 27k | $98k | -43% | Jun 2024 |
|
| Centiva Capital | 25k | $103k | 0% | Sep 2024 |
|
| Golden State Equity Partners | 6.5k | $27k | -74% | Sep 2024 |
|
| Resources Investment Advisors | 18k | $75k | 0% | Sep 2024 |
|
| Advisors Preferred | 18k | $76k | -27% | Sep 2024 |
|
| PFG Investments | 17k | $61k | -46% | Jun 2024 |
|
| BlackRock | 17k | $61k | -49% | Jun 2024 |
|
| Manufacturers Life Insurance Company | 15k | $53k | -88% | Jun 2024 |
|
| BlackRock | 14k | $59k | 100% | Sep 2024 |
|
| Two Sigma Securities | 14k | $50k | 100% | Jun 2024 |
|
| Graham Capital Management | 13k | $52k | 100% | Sep 2024 |
|
| GAMMA Investing | 11k | $44k | 58% | Sep 2024 |
|
| Level Four Advisory Services | 10k | $36k | -50% | Jun 2024 |
|
| Rhumbline Advisers | 7.3k | $30k | 5% | Sep 2024 |
|
| SRS Capital Advisors | 4.0k | $16k | 0% | Sep 2024 |
|
| Lindbrook Capital | 1.7k | $6.8k | 0% | Sep 2024 |
|
| Hanson McClain Advisors | 1.5k | $6.2k | 0% | Sep 2024 |
|
| GPS Wealth Strategies Group | 1.5k | $6.2k | 100% | Sep 2024 |
|
| Bnp Paribas Arbitrage, Snc | 1.4k | $5.8k | -93% | Sep 2024 |
|
| BFSG | 1.0k | $4.1k | 0% | Sep 2024 |
|
| Signature | 679.00 | $2.8k | 0% | Sep 2024 |
|
| Jpmorgan Chase & Co | 365.00 | $1.5k | 0% | Sep 2024 |
|
| New England Capital Financial Advisors | 300.00 | $1.2k | 0% | Sep 2024 |
|
| Wells Fargo & Company | 230.00 | $943.000000 | 0% | Sep 2024 |
|
| Cranbrook Wealth Management | 60.00 | $247.002000 | 100% | Sep 2024 |
|
| Barclays | 38.00 | $0 | 0% | Sep 2024 |
|
| GeoWealth Management | 14.00 | $58.000600 | 100% | Sep 2024 |
|
| Us Bancorp | 13.00 | $52.999700 | 0% | Sep 2024 |
|
Who sold out of Mereo Biopharma Group Plc ads?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Jun 2024 | 3.2M | $12M |
| Cantor Fitzgerald, L. P. | Jun 2024 | 275k | $990k |
| Standard Life Aberdeen | Jun 2024 | 73k | $263k |
| Virtu Financial | Jun 2024 | 14k | $51k |
| Adviser Investments | Jun 2024 | 13k | $45k |
| Newbridge Financial Services Group | Jun 2024 | 12k | $42k |
| Tower Research Capital | Mar 2024 | 7.1k | $24k |
| Pnc Financial Services | Jun 2024 | 4.5k | $16k |
| Ariadne Wealth Management | Jun 2024 | 3.5k | $260k |
| ICA Group Wealth Management | Mar 2024 | 1.0k | $3.3k |
| Quadrant Capital | Jun 2024 | 398.00 | $1.4k |
| Plante Moran Financial Advisors | Jun 2024 | 48.00 | $173.001600 |
| Royal Bank of Canada | Jun 2024 | 28.00 | $0 |